Coarctation Of the Aorta Stent Trial

NCT00552812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 105

Last updated 2016-03-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether Cheatham Platinum bare metal stents are safe and effective in the treatment of native and recurrent aortic coarctation in selected children, adolescents and adults.

Conditions

  • Coarctation of the Aorta

Interventions

DEVICE

Stent therapy of aortic coarctation

Transcatheter delivery of a metallic stent to enlarge region of aortic narrowing caused by the coarctation.

Sponsors & Collaborators

  • Richard E. Ringel

    lead OTHER

Principal Investigators

  • Richard E Ringel, MD · Johns Hopkins University

  • Kathy Jenkins, MD · Harvard University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2012-12-31
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00552812 on ClinicalTrials.gov